PTGS2 and esophageal cancer: CpG ODN led to the activation of NF-κB and enhanced expression of matrix metalloproteinase (MMP)-2, MMP-7, and cyclooxygenase-2 (COX-2) mRNA TLR9 in esophageal cancer suggesting its role in cell proliferation and differentiation [73].